Doxorubicin Induced Cardiomyopathy

Common Name(s)

Doxorubicin Induced Cardiomyopathy

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Doxorubicin Induced Cardiomyopathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Doxorubicin Induced Cardiomyopathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Doxorubicin Induced Cardiomyopathy" returned 10 free, full-text research articles on human participants. First 3 results:

Doxorubicin-induced cardiomyopathy 17 years after chemotherapy.
 

Author(s): Simi Kumar, Ravi Marfatia, Susan Tannenbaum, Clifford Yang, Erick Avelar

Journal: Tex Heart Inst J. 2012 ;39(3):424-7.

 

Doxorubicin, an anthracycline antibiotic commonly used as a chemotherapeutic agent for breast cancer, is well known to cause cardiotoxicity. We report the case of an active, otherwise healthy 57-year-old breast cancer survivor who, 17 years after chemotherapy, presented with symptoms ...

Last Updated: 21 Jun 2012

Go To URL
Inorganic nitrate therapy improves Doxorubicin-induced cardiomyopathy a new window for an affordable cardiovascular therapy for everyone?
 

Author(s): Andreas Daiber, Tommaso Gori, Thomas Münzel

Journal: J. Am. Coll. Cardiol.. 2011 May;57(21):2190-3.

 

Last Updated: 20 May 2011

Go To URL
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
 

Author(s): Partha Mukhopadhyay, Mohanraj Rajesh, Sándor Bátkai, Vivek Patel, Yoshihiro Kashiwaya, Lucas Liaudet, Oleg V Evgenov, Ken Mackie, György Haskó, Pál Pacher

Journal: Cardiovasc. Res.. 2010 Mar;85(4):773-84.

 

Here we investigated the mechanisms by which cardiovascular CB1 cannabinoid receptors may modulate the cardiac dysfunction, oxidative stress, and interrelated cell death pathways associated with acute/chronic cardiomyopathy induced by the widely used anti-tumour compound doxorubicin (DOX).

Last Updated: 11 Feb 2010

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Doxorubicin Induced Cardiomyopathy" returned 1 free, full-text review articles on human participants. First 3 results:

Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.
 

Author(s): Yanti Octavia, Carlo G Tocchetti, Kathleen L Gabrielson, Stefan Janssens, Harry J Crijns, An L Moens

Journal: J. Mol. Cell. Cardiol.. 2012 Jun;52(6):1213-25.

 

The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardiotoxicity. It has been calculated that approximately 10% of patients treated with doxorubicin or its derivatives will develop cardiac complications up to 10 years after the cessation ...

Last Updated: 8 May 2012

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.